Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)

Bing Z. Carter, Po Yee Mak, Wenjing Tao, Edward Ayoub, Lauren B. Ostermann, Xuelin Huang, Sanam Loghavi, Steffen Boettcher, Yuki Nishida, Vivian Ruvolo, Paul E. Hughes, Phuong K. Morrow, Torsten Haferlach, Steven Kornblau, Muharrem Muftuoglu, Michael Andreeff

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Blood Cancer Journal, (2023), 13, 1, (57), 10.1038/s41408-023-00830-w)'. Together they form a unique fingerprint.

Medicine & Life Sciences